科学图书馆
-
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary RevascularizationH Kawashima , PW Serruys, and on behalf of the SYNTAX Extended Survival Investigators et al. -
Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown UnknownsMorrow DA, Wiviott SD.
-
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAIGP Frederick, AJ Kirtane and American College of Cardiology’s Interventional Council and the Society for Cardiovascular Angiography and Interventions.
-
PCI and CABG for Treating Stable Coronary Artery DiseaseT Doenst, A Haverich, P Serruys et al.
-
Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and ImplicationsRidker PM
-
Screening for Atrial Fibrillation With Electrocardiography US Preventive Services Task Force Recommendation StatementUS Preventive Services Task Force
-
2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization)GJ Dehmer, V Badhwar, EA Bermude et al.
-
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseRidker PM, Everett BM, CANTOS Trial Group et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
